Related references
Note: Only part of the references are listed.IL-17-producing human peripheral regulatory T cells retain suppressive function
Gaelle Beriou et al.
BLOOD (2009)
MOG35-55 i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways
Zhilong Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study
Z. Stelmasiak et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Oral fingolimod (FTY720) in multiple sclerosis Two-year results of a phase II extension study
P. O'Connor et al.
NEUROLOGY (2009)
CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis
Hongmei Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-ζ chimeric receptor
Loana Moisini et al.
JOURNAL OF IMMUNOLOGY (2008)
The effects of natalizumab on the innate and adaptive immune system in the central nervous system
Olaf Stueve
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M. Segal et al.
LANCET NEUROLOGY (2008)
Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset
Marc Veldhoen et al.
NATURE IMMUNOLOGY (2008)
IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3- effector T cells
Valerie Dardalhon et al.
NATURE IMMUNOLOGY (2008)
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Yan Zheng et al.
NATURE MEDICINE (2008)
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype
Magdalena Huber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IL-22 is expressed by TH17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis
Katharina Kreymborg et al.
JOURNAL OF IMMUNOLOGY (2007)
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells
Amit Awasthi et al.
NATURE IMMUNOLOGY (2007)
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells
Denise C. Fitzgerald et al.
NATURE IMMUNOLOGY (2007)
IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner
Lai Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Toward the development of rational therapies in multiple sclerosis: What is on the horizon?
Bernhard Hemmer et al.
ANNALS OF NEUROLOGY (2007)
Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis
Denise C. Fitzgerald et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Type II monocytes modulate T cell-mediated central nervous system autoimmune disease
Martin S. Weber et al.
NATURE MEDICINE (2007)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn et al.
NATURE (2007)
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells
Roza Nurieva et al.
NATURE (2007)
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid
Daniel Mucida et al.
SCIENCE (2007)
Tolerization of an established αB-crystallin-reactive T-cell response by intravenous antigen
Richard Verbeek et al.
IMMUNOLOGY (2007)
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Thomas Korn et al.
NATURE MEDICINE (2007)
TH-17 cells in the circle of immunity and autoimmunity
Estelle Bettelli et al.
NATURE IMMUNOLOGY (2007)
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Arian Laurence et al.
IMMUNITY (2007)
Anti-tac (daclizumab, zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: A 25-year personal odyssey
Thomas A. Waldmann
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Expression and regulation of IL-22 in the IL-17-producing CD4+T lymphocytes
Yeonseok Chung et al.
CELL RESEARCH (2006)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Interleukin-22: A novel T- and NK-cell derived cytokine that regulates the biology of tissue cells
Kerstin Wolk et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Effects of glatiramer acetate and interferon-β on neurodegeneration in a model of multiple sclerosis -: A comparative study
Katharina Maier et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Cladribine: An Investigational immunomodulatory agent for multiple sclerosis
Julie A. Brousil et al.
ANNALS OF PHARMACOTHERAPY (2006)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system
Jason S. Stumhofer et al.
NATURE IMMUNOLOGY (2006)
Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells
Marcel Batten et al.
NATURE IMMUNOLOGY (2006)
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Yutaka Komiyama et al.
JOURNAL OF IMMUNOLOGY (2006)
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25-LAP+ T cells
Hirofumi Ochi et al.
NATURE MEDICINE (2006)
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve et al.
ANNALS OF NEUROLOGY (2006)
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
Y Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Management of worsening multiple sclerosis with mitoxantrone: A review
EJ Fox
CLINICAL THERAPEUTICS (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation
Ilona Gutcher et al.
NATURE IMMUNOLOGY (2006)
Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging
L Massacesi et al.
ARCHIVES OF NEUROLOGY (2005)
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
AL Cox et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
HH Hofstetter et al.
CELLULAR IMMUNOLOGY (2005)
Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity
JKH Tan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis
G Pryce et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
A paradoxical role of APCs in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis
GX Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function
V Brinkmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody
JW Rose et al.
ANNALS OF NEUROLOGY (2004)
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Multiple sclerosis:: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo
MS Weber et al.
BRAIN (2004)
Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide - mechanisms independent of pyrimidine depletion
T Korn et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Early administration of IL-12 suppresses EAE through induction of interferon-γ
B Gran et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB 1*0401 Tg mice and their pathogenic potential
J Huh et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation:: relevance for the immune modulatory effect in multiple sclerosis
B Schreiner et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice
AA Vandenbark et al.
JOURNAL OF IMMUNOLOGY (2003)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The 'Immunological-Synapse' at its APC side in relapsing and secondary-progressive multiple sclerosis: modulation by interferon-beta
S Shapiro et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination
B Gran et al.
JOURNAL OF IMMUNOLOGY (2002)
Cutting edge:: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis
AP Kohm et al.
JOURNAL OF IMMUNOLOGY (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Oligoclonal expansion of memory CD8(+) T cells in cerebrospinal fluid from multiple sclerosis patients
M Jacobsen et al.
BRAIN (2002)
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
JW Peterson et al.
ANNALS OF NEUROLOGY (2001)
TCR peptide therapy in human autoimmune diseases
AA Vandenbark et al.
NEUROCHEMICAL RESEARCH (2001)
Mechanisms of action of glatiramer acetate in multiple sclerosis
O Neuhaus et al.
NEUROLOGY (2001)
Mechanisms of immunomodulation by glatiramer acetate
B Gran et al.
NEUROLOGY (2000)
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
B Oppmann et al.
IMMUNITY (2000)
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
B Bielekova et al.
NATURE MEDICINE (2000)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction
H Babbe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Cladribine and progressive MS - Clinical and MRI outcomes of a multicenter controlled trial
GPA Rice et al.
NEUROLOGY (2000)
Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases
ML Herrmann et al.
IMMUNOPHARMACOLOGY (2000)
Glatiramer acetate (Copaxone®) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis
PW Duda et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: Role of regulatory spleen cells
BA Hilliard et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2000)
Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing-remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide
M Ichikawa et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Functional responses and costimulator dependence of memory CD4(+) T cells
CA London et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
